PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMED vs. SYK
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


GMEDSYK
YTD Return20.85%12.02%
1Y Return13.52%18.54%
3Y Return (Ann)-3.60%11.02%
5Y Return (Ann)8.62%13.96%
10Y Return (Ann)10.28%16.82%
Sharpe Ratio0.390.91
Daily Std Dev33.96%20.86%
Max Drawdown-47.91%-58.63%
Current Drawdown-23.39%-6.70%

Fundamentals


GMEDSYK
Market Cap$8.74B$125.93B
EPS$0.54$8.76
PE Ratio119.8537.74
PEG Ratio1.752.92
Revenue (TTM)$1.90B$20.96B
Gross Profit (TTM)$759.12M$11.65B
EBITDA (TTM)$480.82M$5.44B

Correlation

-0.50.00.51.00.5

The correlation between GMED and SYK is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

GMED vs. SYK - Performance Comparison

In the year-to-date period, GMED achieves a 20.85% return, which is significantly higher than SYK's 12.02% return. Over the past 10 years, GMED has underperformed SYK with an annualized return of 10.28%, while SYK has yielded a comparatively higher 16.82% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%700.00%December2024FebruaryMarchAprilMay
377.04%
637.48%
GMED
SYK

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Globus Medical, Inc.

Stryker Corporation

Risk-Adjusted Performance

GMED vs. SYK - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Stryker Corporation (SYK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


GMED
Sharpe ratio
The chart of Sharpe ratio for GMED, currently valued at 0.39, compared to the broader market-2.00-1.000.001.002.003.004.000.39
Sortino ratio
The chart of Sortino ratio for GMED, currently valued at 0.91, compared to the broader market-4.00-2.000.002.004.006.000.91
Omega ratio
The chart of Omega ratio for GMED, currently valued at 1.11, compared to the broader market0.501.001.502.001.11
Calmar ratio
The chart of Calmar ratio for GMED, currently valued at 0.28, compared to the broader market0.002.004.006.000.28
Martin ratio
The chart of Martin ratio for GMED, currently valued at 0.85, compared to the broader market-10.000.0010.0020.0030.000.85
SYK
Sharpe ratio
The chart of Sharpe ratio for SYK, currently valued at 0.91, compared to the broader market-2.00-1.000.001.002.003.004.000.91
Sortino ratio
The chart of Sortino ratio for SYK, currently valued at 1.40, compared to the broader market-4.00-2.000.002.004.006.001.40
Omega ratio
The chart of Omega ratio for SYK, currently valued at 1.18, compared to the broader market0.501.001.502.001.18
Calmar ratio
The chart of Calmar ratio for SYK, currently valued at 1.15, compared to the broader market0.002.004.006.001.15
Martin ratio
The chart of Martin ratio for SYK, currently valued at 3.09, compared to the broader market-10.000.0010.0020.0030.003.09

GMED vs. SYK - Sharpe Ratio Comparison

The current GMED Sharpe Ratio is 0.39, which is lower than the SYK Sharpe Ratio of 0.91. The chart below compares the 12-month rolling Sharpe Ratio of GMED and SYK.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00December2024FebruaryMarchAprilMay
0.39
0.91
GMED
SYK

Dividends

GMED vs. SYK - Dividend Comparison

GMED has not paid dividends to shareholders, while SYK's dividend yield for the trailing twelve months is around 0.93%.


TTM20232022202120202019201820172016201520142013
GMED
Globus Medical, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SYK
Stryker Corporation
0.93%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%1.46%

Drawdowns

GMED vs. SYK - Drawdown Comparison

The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum SYK drawdown of -58.63%. Use the drawdown chart below to compare losses from any high point for GMED and SYK. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-23.39%
-6.70%
GMED
SYK

Volatility

GMED vs. SYK - Volatility Comparison

Globus Medical, Inc. (GMED) has a higher volatility of 19.92% compared to Stryker Corporation (SYK) at 5.56%. This indicates that GMED's price experiences larger fluctuations and is considered to be riskier than SYK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
19.92%
5.56%
GMED
SYK

Financials

GMED vs. SYK - Financials Comparison

This section allows you to compare key financial metrics between Globus Medical, Inc. and Stryker Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items